Cinobufotalin shows efficacy against colon adenocarcinoma and diminishes cisplatin resistance in lung adenocarcinoma and hepatocellular carcinoma via c-Myc degradation through ubiquitination [34,35,36]. This evidence concerns the gene MYC and colon adenocarcinoma.